Huang; Lianfeng

Patent Applications and Registrations

Patent applications and USPTO patent grants for Huang; Lianfeng.The latest application filed is for "solid forms comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methy- l)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and salts thereof, and compositions comprising and methods of using the same".

Company Profile

16.23.32

Huang; Lianfeng - Basking Ridge NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Solid Forms Comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methy- L)benzyl)piperazin-1-yl)-3-fluorobenzonitrile And Salts Thereof, And Compositions Comprising And Methods Of Using The Same App 20220289713 - Artman, III; Gerald D. ; et al.	2022-09-15
Solid forms comprising an oxime ether compound and a coformer, compositions and methods of use thereof Grant 11,434,200 - Huang , et al. September 6, 2	2022-09-06
Solid forms comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methy- l)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and salts thereof, and compositions comprising and methods of using the same Grant 11,370,777 - Artman, III , et al. June 28, 2	2022-06-28
Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof Grant 11,186,556 - Huang , et al. November 30, 2	2021-11-30
Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)pipera- Zine-1-carboxylate, Compositions And Methods Of Use Thereof App 20210363105 - Huang; Lianfeng ; et al.	2021-11-25
Crystalline (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)pipera- zine-1-carboxylate, compositions and methods of use thereof Grant 11,053,199 - Huang , et al. July 6, 2	2021-07-06
Forms And Compositions Of A Mk2 Inhibitor App 20210198276 - Han; Jianxin ; et al.	2021-07-01
Solid forms of a thiazolidinone compound, compositions and methods of use thereof Grant 11,013,723 - Huang , et al. May 25, 2	2021-05-25
Solid forms comprising a thiazolidinone compound, compositions and methods of use thereof Grant 11,014,897 - Huang , et al. May 25, 2	2021-05-25
Solid Forms Comprising an Oxime Ether Compound and a Coformer, Compositions and Methods of Use Thereof App 20210139420 - Huang; Lianfeng ; et al.	2021-05-13
Compositions And Methods Of Use Of Cis-4-[2-{[(3s,4r)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9h- -purin-9-yl]-1-methylcyclohexane-1-carboxamide App 20210128564 - Bone; Scott ; et al.	2021-05-06
Solid Forms Comprising (s)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-y- L)methyl)benzyl)amino)isoindoline-1,3-dione And Salts Thereof, And Compositions Comprising And Methods Of Using The Same App 20210115019 - Huang; Lianfeng ; et al.	2021-04-22
Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H- -purin-9-yl]-1-methylcyclohexane-1-carboxamide Grant 10,898,488 - Bone , et al. January 26, 2	2021-01-26
Forms and compositions of a MK2 inhibitor Grant 10,882,867 - Han , et al. January 5, 2	2021-01-05
Solid Forms Comprising an Oxime Ether Compound, Compositions and Methods of Use Thereof App 20200399213 - Huang; Lianfeng ; et al.	2020-12-24
Solid Forms Comprising An Oxime Ether Compound, Compositions and Methods of Use Thereof App 20200377454 - Huang; Lianfeng ; et al.	2020-12-03
Compositions And Methods Of Use Of Cis-4-[2-{[(3s,4r)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9h- -purin-9-yl]-1-met App 20200237767 - Bone; Scott ; et al.	2020-07-30
Solid Forms Comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methy- L)benzyl)piperazin-1-yl)-3-flu App 20200216418 - Artman, III; Gerald D. ; et al.	2020-07-09
Compositions and methods of use of cis-4-[2-{[3S,4R)-3-fluorooxan-4-yl]amino}8-(2,4,6-trichloroanilino)-9H-p- urin-9-yl]-1-methylcyclohexane-1-carboxamide Grant 10,653,697 - Bone , et al.	2020-05-19
Forms And Compositions Of A Mk2 Inhibitor App 20200148701 - Han; Jianxin ; et al.	2020-05-14
Compositions And Methods Of Use Of Cis-4-[2-{[(3s,4r)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9h- -purin-9-yl]-1-met App 20200113908 - Bone; Scott ; et al.	2020-04-16
Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)pipera- Zine-1-carboxylate, Compositions And Meth App 20200095201 - Huang; Lianfeng ; et al.	2020-03-26
Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyri- midine-5-carboxamide Grant 10,590,089 - Boersen , et al.	2020-03-17
Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H- -purin-9-yl]-1-methylcyclohexane-1-carboxamide Grant 10,543,214 - Bone , et al. Ja	2020-01-28
Solid forms of (1S,4S)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4-yl)amino)-8-((2,4,6-- trichlorophenyl)amino)-9H-purin-9-yl)-1-methylcyclohexane-1-carboxamide and methods of their use Grant 10,513,519 - Chen , et al. Dec	2019-12-24
Compositions And Methods Of Use Of Cis-4-[2-{[(3s,4r)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9h- -purin-9-yl]-1-methylcyclohexane-1-carboxamide App 20190099425 - Bone; Scott ; et al.	2019-04-04
Forms and compositions of an ERK inhibitor Grant 10,202,364 - Ferretti , et al. Feb	2019-02-12
Formulations Of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyri- Midine-5-carboxamide App 20190031619 - BOERSEN; Nathan Andrew ; et al.	2019-01-31
Solid Forms Of (1s,4s)-4-(2-(((3s,4r)-3-fluorotetrahydro-2h-pyran-4-yl)amino)-8-((2,4,6-- Trichlorophenyl)amino)-9h-purin-9-yl)-1-methylcyclohexane-1-carboxamide And Methods Of Their Use App 20180362529 - Chen; Zheng ; et al.	2018-12-20
Forms And Compositions Of An Erk Inhibitor App 20180362498 - Ferretti; Antonio Christian ; et al.	2018-12-20
Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4methylcyclohexylamino)-pyrim- idine-5-carboxamide Grant 10,131,639 - Boersen , et al. November 20, 2	2018-11-20
Solid Forms Of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, And Their Pharmaceutical Compositions And Uses App 20180258064 - Huang; Lianfeng ; et al.	2018-09-13
Solid forms of (1S,4S)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4-yl)amino)-8-((2,4,6-- trichlorophenyl)amino)-9H-purin-9-yl)-1-methylcyclohexane-1-carboxamide and methods of their use Grant 10,047,090 - Chen , et al. August 14, 2	2018-08-14
Forms and compositions of an ERK inhibitor Grant 10,005,760 - Ferretti , et al. June 26, 2	2018-06-26
Formulations Of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyri- Midine-5-carboxamide App 20180009765 - BOERSEN; Nathan Andrew ; et al.	2018-01-11
Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyri- midine-5-carboxamide, compositions thereof and methods of their use Grant 9,814,713 - Man , et al. November 14, 2	2017-11-14
Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-Methylcyclohexylamino)-pyri- midine-5-carboxamide Grant 9,796,685 - Boersen , et al. October 24, 2	2017-10-24
Romidepsin formulations and uses thereof Grant 9,795,650 - Huang , et al. October 24, 2	2017-10-24
Romidepsin formulations and uses thereof Grant 9,782,451 - Huang , et al. October 10, 2	2017-10-10
Solid Forms Of (1s,4s)-4-(2-(((3s,4r)-3-fluorotetrahydro-2h-pyran-4-yl)amino)-8-((2,4,6-- Trichlorophenyl)amino)-9h-purin-9-yl)-1-methylcyclohexane-1-carboxamide And Methods Of Their Use App 20170283418 - Chen; Zheng ; et al.	2017-10-05
Forms And Compositions Of An Erk Inhibitor App 20170226083 - Ferretti; Antonio Christian ; et al.	2017-08-10
Romidepsin Formulations And Uses Thereof App 20170007665 - HUANG; Lianfeng ; et al.	2017-01-12
Romidepsin Formulations And Uses Thereof App 20170000845 - HUANG; Lianfeng ; et al.	2017-01-05
Romidepsin Formulations And Uses Thereof App 20160367625 - HUANG; Lianfeng ; et al.	2016-12-22
Romidepsin formulations and uses thereof Grant 9,468,664 - Huang , et al. October 18, 2	2016-10-18
Romidepsin formulations and uses thereof Grant 9,463,215 - Huang , et al. October 11, 2	2016-10-11
Solid Forms Of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyri- Midine-5-carboxamide, Compositions Thereof And Methods Of Their Use App 20160256459 - Man; Hon-Wah ; et al.	2016-09-08
Formulations Of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyri- Midine-5-carboxamide App 20160168105 - BOERSEN; Nathan Andrew ; et al.	2016-06-16
Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyri- midine-5-carboxamide, compositions thereof and methods of their use Grant 9,365,524 - Man , et al. June 14, 2	2016-06-14
Romidepsin Formulations And Uses Thereof App 20160067303 - HUANG; Lianfeng ; et al.	2016-03-10
Romidepsin Formulations And Uses Thereof App 20160067304 - HUANG; Lianfeng ; et al.	2016-03-10
Romidepsin Formulations And Uses Thereof App 20150182584 - HUANG; Lianfeng ; et al.	2015-07-02
Romidepsin Formulations And Uses Thereof App 20150051157 - HUANG; Lianfeng ; et al.	2015-02-19
Romidepsin Formulations And Uses Thereof App 20130184225 - Huang; Lianfeng ; et al.	2013-07-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.